Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.04 -0.93 (-2.12%)
At close: Sep 30, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Preferred Shares (2011 - 2012)

Updated

Supernus Pharmaceuticals (SUPN) recorded Preferred Shares of $49,000 in Q1 2012, unchanged from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Preferred Shares (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Supernus Pharmaceuticals 2.50 Bn 1.16 Bn 185.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 49,000.00
Dec 31, 2011 49,000.00
API Access

Supernus Pharmaceuticals Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=SUPN&period=max&api_key=YOUR_API_KEY